← Back

DocuSign Inc

DocuSign, Inc. provides electronic signature solution in the United States and internationally. The company offers AI-powered intelligent agreement management (IAM) platform to optimize the gain intelligence and automation across the entire agreement lifecycle; and provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; and Document Generation streamlines the process of generating new, custom agreements. It also provides Identify, a signer-identification option for checking government-issued IDs; Standards-Based Signatures, which support signatures that involve digital certificates; Monitor that uses advanced analytics; Notary which enables notaries public to conduct remote online notarization transactions; and Web Forms. In addition, the company offers Real Estate for eSignature that provides a way for brokers and agents to manage the entire real estate transaction digitally. eSignature and CLM are Federal Risk and Authorization Management Program (FedRAMP), an authorized version of DocuSign eSignature for U.S. federal government agencies; and life sciences modules that support compliance with the electronic signature practices. The company sells its products through direct and partner-assisted sales, and digital self-service purchasing. DocuSign, Inc. was incorporated in 2003 and is headquartered in San Francisco, California.

Price · split & dividend adjusted
News & notes moving DOCU
DOCU

DocuSign and Oracle Shares Jump After Soft PPI Data Eases Rate Fears

DocuSign and Oracle shares rose sharply in afternoon trading after a softer-than-expected Producer Price Index report eased inflation concerns and lifted growth stocks. DocuSign gained 3% and Oracle climbed 3.3% as the June wholesale inflation reading fell 0.3% versus expectations for a flat print, following a 0.4% decline in consumer prices the prior session. The data reduced pressure on the Federal Reserve to keep interest rates high, mechanically boosting valuations for companies reliant on future cash flows. The rally countered fears of an IT budget squeeze sparked a day earlier by IBM's warning that clients are reprioritizing capital expenditures toward AI servers and high-bandwidth memory.
Yahoo Finance·42dRead more ▾
DOCU

StockStory Highlights Comfort Systems and BioMarin as Cash-Rich Picks, Flags DocuSign as a Sell

StockStory identifies two cash-heavy stocks with exciting potential and one to ignore. DocuSign, with a net cash position of $630.8 million representing 7.4% of its market cap, is flagged as a sell due to underwhelming annual recurring revenue growth of 8.5% and high competitive spending. Comfort Systems, holding $1.01 billion in net cash or 1.6% of market cap, is viewed bullishly thanks to 53.1% average backlog growth over two years and a 9.5 percentage point increase in free cash flow margin over five years. BioMarin Pharmaceutical, with $782.8 million in net cash equating to 7.3% of market cap, is favored for its 14.5% annual revenue growth over two years and projected 28.4% revenue increase. Comfort Systems trades at $1,857 per share and 45.7 times forward earnings, while BioMarin is at $56.05 per share and 10.2 times forward earnings.
StockStory·58dRead more ▾
DOCU

DocuSign Consensus Earnings Estimates Revised Upward Over Past Month

DocuSign has seen its consensus earnings estimates revised upward over the past month. The Zacks Consensus Estimate for the current quarter has increased 11.7% to $1.08 per share, while the current fiscal year estimate has risen 12.4% to $4.53. For the next fiscal year, the estimate has edged up 1.6% to $5.11. The stock carries a Zacks Rank #3, suggesting it may perform in line with the broader market.
Zacks Investment Research·62dRead more ▾
DOCU

DocuSign shares rise 3.3% as falling Treasury yields boost software valuations

DocuSign shares jumped 3.3% in afternoon trading as the 10-year Treasury yield dropped below 4.5%, providing valuation relief amid a broader tech pullback. The decline in yields, driven by sliding oil prices and easing inflation pressures, mechanically boosts the present value of future cash flows for high-growth software companies. While semiconductor stocks dragged the Nasdaq lower, software names like Salesforce and ServiceNow found relative support. DocuSign traded at $44.18, up 3.5% from the previous close, but remains down 31.9% year-to-date and 48% below its 52-week high of $85.01 from September 2025.
Yahoo Finance·63dRead more ▾
Artificial Intelligence2

Docusign IAM platform now available for Perplexity Computer to automate contract workflows

Docusign announced that its Intelligent Agreement Management platform is now available for Perplexity Computer and Computer for Counsel, enabling legal teams to automate contract workflows with AI. The integration, powered by the Docusign Model Context Protocol server, allows users to set objectives in plain language and automate tasks such as vendor compliance reviews, deal negotiations, and HR employment agreements. Docusign CEO Allan Thygesen said the move brings agreement intelligence directly into the AI tools legal teams already use, reducing time spent on manual tasks. Perplexity General Counsel Nathan Barksdale noted that connecting Docusign to Computer enables end-to-end automation of agreement workflows. The integration is available today in English globally.
PR Newswire·63dRead more ▾
DOCU

Docusign Benefits From Subscription Revenues and Tech Partnerships Amid Liquidity Concerns

Docusign is benefiting from rising eSignature demand and recurring subscription revenues, but faces concerns over its pricing structure and low liquidity. The company grew its customer base from 1.3 million in fiscal 2023 to 1.8 million in fiscal 2026, with international revenues rising to 29% of total revenues in fiscal 2026. Expanded partnerships with Salesforce and Microsoft, including integrating eSignature with Microsoft Teams, support its ecosystem. However, a current ratio of 0.73 at the end of the fourth quarter of 2026, well below the industry average of 1.92, pressures profitability and scalability, while the absence of dividends makes the stock less attractive to income-seeking investors.
Zacks Investment Research·64dRead more ▾